Scinai Immunotherapeutics Ltd. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Scinai Immunotherapeutics Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2021 to Q2 2025.
  • Scinai Immunotherapeutics Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2025 was -$122M, a 4.06% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$122M +$5.14M +4.06% Jun 30, 2025 6-K 2025-09-02
Q4 2024 -$118M +$4.8M +3.92% Dec 31, 2024 6-K 2025-09-02
Q2 2024 -$127M -$3.7M -3.01% Jun 30, 2024 6-K 2024-09-09
Q4 2023 -$122M -$6.5M -5.61% Dec 31, 2023 20-F 2025-05-07
Q2 2023 -$123M Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 -$119M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$116M -$5.8M -5.27% Dec 31, 2022 20-F 2024-05-15
Q4 2021 -$110M Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.